Coffee as medicine? caffeine shows promise for rare movement disorder

NCT ID NCT04351360

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This small pilot study looked at whether caffeine can ease involuntary movements in people with a rare genetic condition called ADCY5-related dyskinesia. Fifteen participants took caffeine and reported how much their symptoms improved. The goal was to see if at least 40% of people felt significant relief from their movement problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADCY5-RELATED DYSKINESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Département de Neurologie Groupe Hospitalier Pitié-Salpêtrière

    Paris, 75651 PARIS Cedex 13, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.